| Description | Sultosilic acid piperazine salt (A-585) is a novel lipid-lowering compound that can be used to study type IIb familial combined hyperlipidemia. |
| Synonyms | Piperazine-sultosylate, A-585, Mimedran, A585, A 585 |
| molecular weight | 430.5 |
| Molecular formula | C17H22N2O7S2 |
| CAS | 57775-27-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Vinazzer H,et al. Double-blind cross-over study of the effect of sultosilic acid piperazine salt (A-585) and bezafibrate in primary hyperlipoproteinemia. Atherosclerosis. 1983 Nov;49(2):109-18. 2. Vinazzer H,et al. [Comparison of the antilipemic effect of bezafibrate with that of piperazine-sultosilate (A 585). A crossed double-blind study]. Wien Klin Wochenschr. 1984 Dec 21;96(24):889-93. German. 3. Rodríguez L, et al. [Toxicologic study of piperazine sultosylate (A-585)]. Arch Farmacol Toxicol. 1979 Dec;5(3):281-3.Spanish. 4. Casellas Bernat A, et al.[Clinical effectiveness of piperazine sultosylate in the hyperlipidemias]. Rev Clin Esp. 1981 Apr 25;161(1):5-8. Spanish. |
Sultosilic acid piperazine salt
CAS No.: 57775-27-6
Sultosilic acid piperazine salt (A-585) is a novel lipid-lowering compound that can be used to study type IIb familial c
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.